Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, X-Linked

Explore clinical trials studying Genetic Diseases, X-Linked. Study availability and eligibility vary by location and protocol.

1,244 public trials 227 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, X-Linked trial results

Completed

Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B

NCT01027364

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Sacramento, California, United States
  • Research Site Aurora, Colorado, United States
  • Research Site Chicago, Illinois, United States
View all 51 locations
View Trial Details
Completed

Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)

NCT01482143

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Novartis Investigative Site Sacramento, California, United States
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Nashville, Tennessee, United States
  • Novartis Investigative Site Sant Cugat del Vallès, Catalonia, Spain
View Trial Details
Completed

Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada

NCT01557400

Conditions
Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, +10 more
Locations
  • Royal Children's Hospital Parkville, Melbourne, Australia
  • Institute For Neuromuscular Research, The Children's Hospital at Westmead Westmead, Australia
  • University Hospital KU Leuven Leuven, Belgium
  • Alberta Children's Hospital Calgary, Alberta, Canada
View all 21 locations
View Trial Details
Completed

Diversion-p64 Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device

NCT02600364

Conditions
Aneurysm, Brain Diseases, Cardiovascular Diseases, +16 more
Locations
  • Clínica La Sagrada Familia Buenos Aires, Argentina
  • Ziekenhuis Oost-Limburg Genk, Belgium
  • St. Ivan Rilski Hospital Sofia, Bulgaria
  • Groupe Hospitalier Pellegrin Bordeaux, France
View all 26 locations
View Trial Details

Related conditions